James Larsen Foundation For Esophageal Cancer New York City, NY - 10017

James Larsen Foundation For Esophageal Cancer is categorized under in New York City, NY and active since 2008.

James Larsen Foundation For Esophageal Cancer was established in 2008, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 813211 by the NAICS.

If you are seeking more information, feel free to contact Joanne Kolker at the company’s single location by writing to 529 5th Avenue Floor 9, New York City, New York NY 10017 or by phoning (570) 222-7772. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: James Larsen Foundation For Esophageal Cancer
Contact Person: Joanne Kolker
Address: 529 5th Avenue Floor 9, New York City, New York 10017
Phone Number: (570) 222-7772
Annual Revenue (USD): $50.000 to $99.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 6732
NAICS Code: 813211
Share This Business:

James Larsen Foundation For Esophageal Cancer was started in 2008 to provide professional under the SIC code 6732 and NAICS code 813211. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Joanne Kolker for inquiries that concern James Larsen Foundation For Esophageal Cancer by calling the company number (570) 222-7772, as your correspondence is most welcome. Additionally, the physical location of the single location of James Larsen Foundation For Esophageal Cancer can be found at the coordinates 40.754604,-73.979867 as well as the street address 529 5th Avenue Floor 9 in New York City, New York 10017.

For its online presence, you may visit James Larsen Foundation For Esophageal Cancer’s website at and engage with its social media outlets through on Twitter and on Facebook.